SOR III Year 2 CSB/Agency-level GPRA Intake Reports Now Available

Greetings!

OMNI is pleased to share customized GPRA Annual report(s) for your CSB/Agency. Similar to the full SOR statewide report your agency report contains compiled GPRA data specific to your CSBs/Agency from the SOR III Year 2 time period (October 2023 through September 2024). This reflects Year 6 of the SOR Grant.

  • All CSBs/Agencies are provided with an Intake report. This report contains demographic and baseline characteristics of your clientele cohort.

  • Some CSBs/Agencies also receive an Outcomes report to that includes demographic and baseline characteristics and matched “outcomes” based on follow-up or discharge data. Only those who have more that 10 matched pairs of Intake and Outcome reports will receive this particular report.

  • Each Intake Report summarizes the data collected through the GPRA intake surveys to understand characteristics and reported behaviors of respondents at time of intake during SOR III Year 2.

  • The Outcomes Report compares individuals’ responses from the Intake GPRA with their latest assessment GPRA survey for a select number of outcomes. “Latest assessment GPRA” encompasses the most recent GPRA survey, which could be a follow-up or a discharge GPRA.

  • To protect the privacy of respondents, results with fewer than 10 responses are suppressed and marked with “N/A” in both reports.

  • In the Outcomes report, statistical methods were applied to ensure accurate interpretation of the data. A statistically significant difference (marked by *) indicates that the observed change between intake and the latest assessment is unlikely due to chance, with a p-value less than 0.05.

  • In the Outcomes report, the “confidence interval (CI)” represents the range within which the true population value is expected to fall based on the sample data. A narrower confidence interval suggests a more precise estimate, while a wider range indicates greater uncertainty. In the bar charts, orange I-beam markers depict the upper and lower boundaries of these intervals to illustrate the potential variation in results.

You may wish to compare your CSB/Agency report data with the full SOR III Year 2 Annual Report Treatment findings which will soon be available here on the website.

If you have any questions or feedback regarding the report, or want to chat about the results, please don't hesitate to reach out to us at SORSupport@omni.org.

Thanks so much,

The OMNI SOR team

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.